0001209191-21-014562.txt : 20210225
0001209191-21-014562.hdr.sgml : 20210225
20210225215647
ACCESSION NUMBER: 0001209191-21-014562
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20210223
FILED AS OF DATE: 20210225
DATE AS OF CHANGE: 20210225
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Lichter Jay
CENTRAL INDEX KEY: 0001376355
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36591
FILM NUMBER: 21683527
MAIL ADDRESS:
STREET 1: C/O ARATANA THERAPEUTICS, INC.
STREET 2: 11400 TOMAHAWK CREEK PARKWAY, SUITE 340
CITY: LEAWOOD
STATE: KS
ZIP: 66211
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: OTONOMY, INC.
CENTRAL INDEX KEY: 0001493566
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 262590070
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 4796 EXECUTIVE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
BUSINESS PHONE: (619) 323-2200
MAIL ADDRESS:
STREET 1: 4796 EXECUTIVE DRIVE
CITY: SAN DIEGO
STATE: CA
ZIP: 92121
FORMER COMPANY:
FORMER CONFORMED NAME: Otonomy, Inc.
DATE OF NAME CHANGE: 20100607
4
1
doc4.xml
FORM 4 SUBMISSION
X0306
4
2021-02-23
0
0001493566
OTONOMY, INC.
OTIC
0001376355
Lichter Jay
C/O OTONOMY, INC.
4796 EXECUTIVE DRIVE
SAN DIEGO
CA
92121
1
0
0
0
Common Stock
2021-02-23
4
S
0
173005
2.888
D
1309383
I
See footnote
Common Stock
2021-02-24
4
S
0
324651
2.982
D
984732
I
See footnote
Common Stock
2021-02-25
4
S
0
200739
2.954
D
783993
I
See footnote
Common Stock
2021-02-23
4
S
0
95113
2.888
D
719860
I
See footnote
Common Stock
2021-02-24
4
S
0
178484
2.982
D
541376
I
See footnote
Common Stock
2021-02-25
4
S
0
110361
2.954
D
431015
I
See footnote
This sale price represents the weighted average sale price of the shares sold ranging from $2.875 to $2.945 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Holder will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
Shares are held by Avalon Ventures VIII, L.P. ("Avalon VIII"). The Reporting Person is a managing director of Avalon VIII and shares voting and dispositive power with respect to these shares.
This sale price represents the weighted average sale price of the shares sold ranging from $2.82 to $3.14 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Holder will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
This sale price represents the weighted average sale price of the shares sold ranging from $2.895 to $3.02 per share. Upon request by the Commission staff, the Issuer, or a security holder of the Issuer, the Holder will provide full information regarding the number of shares sold at each separate price within the range set forth in this Form 4.
Shares are held by Avalon Ventures X, L.P. ("Avalon X"). The Reporting Person is a managing director of Avalon X and shares voting and dispositive power with respect to these shares.
/s/ Paul E. Cayer, Attorney-in-fact
2021-02-25